Skip to main content
MDGL logo

MDGL · Madrigal Pharmaceuticals, Inc.

$546.79 +11.10 (+2.07%) At close · Jul 21
Market Cap
$12.61B
Shares
23.06M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Bill Sibold $19,206,341
David Soergel $9,190,678
Rebecca Taub $6,868,016
Mardi Dier $6,085,089
Carole Huntsman $5,441,736
Shannon Kelley $5,179,352
Fiscal 2024
Executive Total
Bill Sibold $12,214,250
Mardi Dier $8,751,912
Rebecca Taub $5,967,206
Shannon Kelley $4,673,764
Carole Huntsman $3,949,441
Fiscal 2023
Executive Total
Bill Sibold $32,268,400
Paul Friedman $9,563,286
Remy Sukhija $7,362,378
Rebecca Taub $6,928,008
Brian J. Lynch $5,266,584
Alex Howarth $5,262,023
Carole Huntsman $3,142,354
Fiscal 2022
Executive Total
Paul Friedman $5,395,385
Brian J. Lynch $4,758,149
Rebecca Taub $4,664,881
Remy Sukhija $3,510,849
Alex Howarth $3,482,906
Fiscal 2021
Executive Total
Alex Howarth $7,131,804
Paul Friedman $5,318,389
Rebecca Taub $4,610,146
Marc R. Schneebaum $3,704,789
Brian J. Lynch $3,430,481
Remy Sukhija $2,768,467
Fiscal 2020
Executive Total
Paul Friedman $4,535,446
Brian J. Lynch $4,447,893
Rebecca Taub $3,882,343
Remy Sukhija $3,438,902
Marc R. Schneebaum $2,940,472
Fiscal 2019
Executive Total
Paul Friedman $6,093,192
Rebecca Taub $5,269,843
Brian J. Lynch $4,068,637
Marc R $3,532,652
Marc R. Schneebaum $3,532,652
Fiscal 2018
Executive Total
Paul Friedman $5,628,666
Rebecca Taub $4,340,446
Marc R $3,366,100
Marc R. Schneebaum $3,366,100
Fiscal 2017
Executive Total
Paul Friedman $1,364,982
Rebecca Taub $1,091,795
Marc R $970,294
Key facts CIK 1157601 CUSIP 558868105 13F (30d) 37 filings 36 filers Visit website Investor relations